Sundry Photography/iStock Editorial via Getty Images
Sundry Photography/iStock Editorial via Getty Images
Sundry Photography
Johnson & Johnson (NYSE: JNJ) traded lower on Wednesday after the MedTech giant disclosed a temporary pause in U.S. cases treated with its Varipulse Pulsed Field Ablation Platform, which targets the cardiac disorder atrial fibrillation.
It follows four neurovascular events
https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1180491673/image_1180491673.jpg?io=getty-c-w750
2025-01-08 12:31:34
